European Journal of Medicinal Chemistry 2008-04-01

Antimycobacterial activity of diphenylpyraline derivatives.

Robert Weis, Johanna Faist, Ulrike di Vora, Klaus Schweiger, Barbara Brandner, Andreas J Kungl, Werner Seebacher

Index: Eur. J. Med. Chem. 43 , 872-9, (2008)

Full Text: HTML

Abstract

2-Substituted derivatives of diphenylpyraline and their 1-phenyl and 1-phenethyl analogues have been prepared in several steps from dihydropyridine-2(1H)-thiones. The structures of all new compounds have been confirmed by NMR spectroscopy. Their activity against Mycobacterium tuberculosis H(37)Rv as well as their cytotoxicity against human cells (HEK-293) have been determined via in vitro assays. The antimycobacterial potency was in general increased by substitution in ring position 2. The most promising modifications were a 2-isopropyl derivative and a 1,2-diphenyl analogue.


Related Compounds

Related Articles:

A possible approach to the suppression of side effects induced by PGE1.

1995-01-01

[Prostaglandins Leukot. Essent. Fatty Acids 52(1) , 17-20, (1995)]

Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry.

2006-01-01

[Rapid Commun. Mass Spectrom. 20(4) , 537-43, (2006)]

Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.

2012-05-15

[Eur. J. Pharmacol. 683(1-3) , 161-5, (2012)]

Effects of H1 antihistamines on canine nasal vascular and airway resistances.

1987-06-01

[Rhinology 25(2) , 95-100, (1987)]

[Parkinsonism associated with cerebrotendinous xanthomatosis].

1990-09-01

[Rinsho. Shinkeigaku 30(9) , 978-84, (1990)]

More Articles...